Luvox and alanine aminotransferase increased Patient Reports February 12, 2012

Luvox Side Effects Report #5649042-9
Luvox side effect was reported by a Physician from JAPAN on Feb 13, 2008. Male patient, 39 years of age, was diagnosed with obsessive-compulsive disorder  and was treated with Luvox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, coagulopathy, convulsion, hepatic function abnormal, prothrombin time prolonged, renal impairment, white blood cell count increased. Luvox dosage: 200 MG, D, ORAL. During the same period patient was treated with PAROXETINE, TEPRENONE, NITRAZEPAM, ZOLPIDEM TARTRATE. Patient recovered.

Luvox Side Effects Report #5678071-4
Luvox side effect was reported by a Physician from JAPAN on Mar 03, 2008. Male patient, 39 years of age, was diagnosed with obsessive-compulsive disorder  and was treated with Luvox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, coagulopathy, convulsion, liver disorder, liver function test abnormal, renal impairment, white blood cell count increased. Luvox dosage: 200 MG, D, ORAL, 150 MG, D, ORAL. During the same period patient was treated with PAROXETINE, TEPRENONE, NITRAZEPAM, ZOLPIDEM TARTRATE. Patient recovered.

Luvox Side Effects Report #5715567-0
Luvox side effect was reported by a Physician from JAPAN on Apr 01, 2008. Male patient, 39 years of age, was diagnosed with obsessive-compulsive disorder  and was treated with Luvox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, cerebral atrophy, coagulopathy, cognitive disorder, convulsion, dialysis . Luvox dosage: 200 MG 950 MG, 4 IN 1 D), ORAL; 150 MG, D, ORAL; 200 MG, D, ORAL; TAKEN A FEW DAYS, ORAL. During the same period patient was treated with PAROXETINE, TEPRENONE, NITRAZEPAM, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient recovered.

Luvox Side Effects Report #5776163-2
Luvox side effect was reported by a Physician from JAPAN on May 29, 2008. Female patient, 68 years of age, was diagnosed with depression  and was treated with Luvox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, hepatic function abnormal. Luvox dosage: (50 MG, 1 D), ORAL; (100 MG, 1 D), ORAL; (150 MG, 1 D), ORAL; (50 MG, 1 D), ORAL. During the same period patient was treated with CLARITHROMYCIN, AMLODIPINE BESYLATE, RALOXIFENE, ACETYLSALICYLIC ACID SRT, MOSAPRIDE CITRATE. Patient recovered.


Luvox Side Effects Report #5797180-2
Luvox side effect was reported by a Physician from JAPAN on June 13, 2008. Male patient, 58 years of age, was diagnosed with depression  and was treated with Luvox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. Luvox dosage: (100 MG, 1 D), ORAL. During the same period patient was treated with VOGLIBOSE, EPALRESTAT, CANDESARTAN CILEXETIL, TELMISARTAN, AMLODIPINE BESYLATE, BENFOTIAMINE, ZOLPIDEM TARTRATE. Patient recovered.

Luvox Side Effects Report #5811468-8
Luvox side effect was reported by a Physician from JAPAN on June 27, 2008. Male patient, 58 years of age, was diagnosed with depression , diabetes mellitus, diabetic neuropathy, constipation , hypertension, iron deficiency anaemia and was treated with Luvox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. Luvox dosage: (100 MG, 1 D), ORAL. During the same period patient was treated with VOGLIBOSE, EPALRESTAT, CANDESARTAN CILEXETIL, FERROUS FUMARATE, TELMISARTAN, BENFOTIAMINE, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient recovered.

Luvox Side Effects Report #5834794-5
Luvox side effect was reported by a Physician from JAPAN on June 13, 2008. Male patient, 58 years of age, was diagnosed with depression , diabetes mellitus, diabetic neuropathy, constipation  and was treated with Luvox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, hepatic function abnormal. Luvox dosage: (100 MG, 1 D), ORAL. During the same period patient was treated with VOGLIBOSE, EPALRESTAT, TELMISARTAN, BENFOTIAMINE, ZOLPIDEM TARTRATE, MOSAPRIDE CITRATE, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Luvox Side Effects Report #5839500-6
Luvox side effect was reported by a Physician from JAPAN on July 25, 2008. Male patient, 58 years of age, was diagnosed with depression , diabetes mellitus, diabetic neuropathy, constipation , hypertension, iron deficiency anaemia and was treated with Luvox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. Luvox dosage: (100 MG, 1 D), ORAL. During the same period patient was treated with VOGLIBOSE, EPALRESTAT, CANDESARTAN CILEXETIL, FERROUS FUMARATE, TELMISARTAN, BENFOTIAMINE, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient recovered.

Luvox Side Effects Report #5706434-7
Luvox side effect was reported by a Physician from JAPAN on Mar 27, 2008. Female patient, 53 years of age, was diagnosed with depression , prophylaxis of nausea and vomiting and was treated with Luvox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, chromaturia, gamma-glutamyltransferase increased, hyperplastic cholecystopathy, jaundice , liver disorder. Luvox dosage: (50 MG,1 D),ORAL; (75 MG,1 D), ORAL; (100 MG,1 D),ORAL; (125 MG,1 D), ORAL;. During the same period patient was treated with MOSAPRIDE CITRATE. Patient was hospitalized. Patient recovered.


Luvox Side Effects Report #5631993-2
Luvox side effect was reported by a Physician from JAPAN on Jan 28, 2008. Male patient, 38 years of age, was diagnosed with depression  and was treated with Luvox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, alcohol use, blood cholesterol increased, blood creatinine increased, blood potassium decreased, blood sodium decreased, blood triglycerides increased, blood uric acid increased, fatigue. Luvox dosage: (150 MG, 1 D, ORAL). During the same period patient was treated with RISPERIDONE, ZOPICLONE, RILMAZAFONE HYDROCHLORIDE, PAROXETINE, OLANZAPINE, BROTIZOLAM, TRIAZOLAM. Patient recovered.

Luvox Side Effects Report #5768145-1
Luvox side effect was reported by a Physician from JAPAN on May 22, 2008. Female patient, 32 years of age, was diagnosed with depression  and was treated with Luvox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, liver disorder. Luvox dosage: 50 MG, 1 D, ORAL. During the same period patient was treated with PAROXETINE, INSULIN GLARGINE, INSULIN LISPRO. Patient was hospitalized. Patient recovered.

Luvox Side Effects Report #6024836-9
Luvox side effect was reported by a Health Professional from GERMANY on Dec 16, 2008. Female patient, 18 years of age, was diagnosed with depression , gastric ulcer and was treated with Luvox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blister, blood cholinesterase decreased, erythema multiforme, haematocrit decreased, haemoglobin decreased, lip blister. Luvox dosage: 50 MG, 1 D, ORAL. During the same period patient was treated with AMOXAPINE, IRSOGLADINE MALEATE, FLUDIAZEPAM, FLUNITRAZEPAM, QUETIAPINE FUMARATE, ALPRAZOLAM, QUAZEPAM. Patient was hospitalized. Patient recovered.

Luvox Side Effects Report #4592648-9
Luvox side effect was reported by a Health Professional from on July 27, 2004. Male patient, weighting 196.2 lb, was diagnosed with depression , chemical poisoning and was treated with Luvox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, c-reactive protein increased, neuroleptic malignant syndrome, white blood cell count increased. Luvox dosage: unknown. During the same period patient was treated with MYSLEE, ROHYPNOL, ANAFRANIL, DEPAS, RISPERDAL, WINTERMIN. Patient was hospitalized. Patient recovered.